PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.86%
Revenue growth similar to MCHP's 10.82%. Walter Schloss would see if both companies share industry tailwinds.
0.99%
Gross profit growth under 50% of MCHP's 15.09%. Michael Burry would be concerned about a severe competitive disadvantage.
3232.57%
EBIT growth above 1.5x MCHP's 140.04%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
3232.57%
Operating income growth above 1.5x MCHP's 132.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-8.90%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.50%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10.00%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-18.38%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
16.37%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-9.44%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
36.22%
Similar OCF growth to MCHP's 33.85%. Walter Schloss would assume comparable operations or industry factors.
88.24%
FCF growth above 1.5x MCHP's 34.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
106.37%
10Y revenue/share CAGR above 1.5x MCHP's 51.09%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
57.31%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
53.45%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.10%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
440.05%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
56.48%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
370.04%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
70.39%
Below 50% of MCHP's 145.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
50.67%
5Y equity/share CAGR above 1.5x MCHP's 14.52%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
11.63%
3Y equity/share CAGR at 50-75% of MCHP's 17.81%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-29.09%
Cut dividends over 10 years while MCHP stands at 180.63%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
31.31%
Below 50% of MCHP's 175.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-15.96%
Negative near-term dividend growth while MCHP invests at 81.65%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.13%
AR growth is negative/stable vs. MCHP's 10.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-7.95%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.04%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
23.65%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-1.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
6.65%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.